Slides for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee

FDA Opening Remarks

Rafel (Dwaine) Rieves, M.D.

Director Division of Medical Imaging and Hematology Products,

CDER, OND, OODP [PDF]

FDA

Kathy Robie-Suh, M.D.

Medical Officer/Team Leader, Division of Medical Imaging and Hematology Products, CDER, OND, OODP [PDF]

Min Lu, M.D., M.P.H.

Medical Officer, Division of Medical Imaging and Hematology Products,

CDER, OND, OODP [PDF]

Qing Xu, Ph.D.

Statistical Reviewer, Office of Biostatistics, Division of Biometrics V [PDF]

Kate Gelperin, M.D., M.P.H.

Medical Officer, Office of Surveillance and Epidemiology, Division of Epidemiology I [PDF]

Christoffer W. Tornoe, Ph.D.

Division of Pharmacometrics, Office of Clinical Pharmacology [PDF]

Sponsor

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. 

Core Presentation  [PDF]

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Backup Files [PDF]

Open Public Hearing Speaker

Speaker #1 [PDF]